Navigation Links
Mushroom found to be a source of a new antibiotic: Plectasin

Animals and higher plants are known to express endogenous peptide antibiotics called defensins, which are small cysteine-rich peptides found to be active against bacteria, fungi and viruses//.

A recent research, published in the October issue of Nature, describes plectasin-the first defensin to be isolated from a fungus, the saprophytic ascomycete Pseudoplectania nigrella. Plectasin has primary, secondary and tertiary structures that closely resemble those of defensins found in spiders, scorpions, dragonflies and mussels. Recombinant plectasin was produced at a very high, and commercially viable, yield and purity at the Danish biotechnology company Novozymes.

During the studies, the compound showed potent activity against a range of Gram-positive bacteria, including several strains resistant to conventional antibiotics, but was found less effective against Gram-negative microbes, the researchers noted.

In mice inoculated with a potentially lethal dose of S. pneumoniae in the peritoneum, plectasin was as effective as vancomycin. Plectasin treated mice were more likely to be alive seven days after infection compared with mice in the control arm. In a mouse model of pneumonia, plectasin and penicillin again had comparable efficacy, the researchers found.

The compound showed no evidence of toxicity in the mice, and is excreted without change in the urine of mice, which is a sign that it is safe and effective. However, the authors add that further study will be needed to see if it is safe to use in humans.

The results indicate that Plectasin showed extremely low toxicity in mice, and cured them of experimental peritonitis and pneumonia caused by S. pneumoniae as efficaciously as vancomycin and penicillin.

The authors conclude on the note that these findings identify fungi as a novel source of antimicrobial defensins, and show the therapeutic potential of plectasin. They also suggest that the defensins of insects , molluscs and fungi arose from a common ancestral gene.
'"/>




Related medicine news :

1. Mushroom and muscle loss
2. Mushrooms can help fight chronic disease
3. Mushroom found to contain powerful antibiotic
4. Novel Vitamin D source in Mushrooms!
5. Mushrooms are Rich Source of Antioxidants
6. A Mushroom Extract May Impact the Body’s Immune Syste
7. Four of Family Died After Consuming Poisonous Mushrooms
8. Mushroom Extract Protects Poultry From Parasite Diseases
9. Magic Mushrooms Treat Obsessive Compulsion Disorder
10. Private Health-care Clinics Mushroom in Ontario
11. Much Room for Cancer Cure in a Mushroom, Scientists Promise
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/24/2017)... ... January 23, 2017 , ... The January 2017 issue of the ... study on how outdoor behavioral healthcare (OBH) – also known as wilderness therapy – ... while experiencing an increased sense of purpose both during and after treatment. , ...
(Date:1/24/2017)... ... January 23, 2017 , ... ... a new plugin that allows sleep centers to automatically connect and initialize all ... a thin client browser plugin is quickly installed on first use and then ...
(Date:1/23/2017)... Alto, CA (PRWEB) , ... ... ... a provider of translation and localization services for life science companies, has ... and inspection organization, TÜV SÜD America. ISO 17100 is the globally recognized ...
(Date:1/23/2017)... ... 23, 2017 , ... Wooden and plastic balance boards have been around since at least the ... Board is the first and only balance board to use a patent-pending design featuring ... at the same time as well as skill-level adjustable for all ages and abilities. ...
(Date:1/23/2017)... Indiana (PRWEB) , ... January 23, 2017 , ... ... Center for Assisted Living (IHCA/INCAL), will serve as a healthcare industry expert at ... 23. The panel discussion, moderated by Inside Indiana Business host Gerry Dick, will ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... Stock-Callers.com today presents the following Generic ... CPRX ), Sophiris Bio Inc. (NASDAQ: SPHS ), ... Therapeutics Inc. (NASDAQ: AGRX ). These companies are ... late trade on Friday, January 20 th , 2017, with ... of health care companies in the S&P 500 also were ...
(Date:1/23/2017)... , January 23, 2017 The global  anxiety disorders and ... by 2025. The rising incidence of depression worldwide is anticipated to drive the ... resulted in the declining demand for antidepressants in the recent years. ... ... Grand View Research Logo ...
(Date:1/23/2017)... DIEGO and PALMA, Spain ... Laboratoris Sanifit S.L., a clinical-stage biopharmaceutical company ... that the first patient has been enrolled in ... lead candidate, SNF472, for the treatment of cardiovascular ... (HD). Most ESRD patients, in the ...
Breaking Medicine Technology: